2 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
Follow Rickets: new trials by email Literature Review of Rickets trials Research Report on Rickets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy Yougui granules, Zuogui granules, Yougui granules placebo - Renal Insufficiency, Chronic, Renal Osteodystrophy | Phase 2 | Withdrawn | Bing Shu | 2012-08-01 | 2017-05-08 | |
| Safety and Efficacy Study of ENB-0040 in Juvenile Patients With Hypophosphatasia (HPP) ENB-0040 - Hypophosphatasia | Phase 2 | Withdrawn | Alexion Pharmaceuticals, Inc. | 2009-07-01 | 2023-08-04 |
Chronic Kidney Disease-Mineral and Bone Disorder (1) · Hypophosphatasia (1) · Osteomalacia (1) · Renal Insufficiency, Chronic (1)
Avitaminosis (2) · Bone Diseases (2) · Bone Diseases, Metabolic (2) · Calcium Metabolism Disorders (2) · Deficiency Diseases (2) · Malnutrition (2) · Metabolic Diseases (2) · Musculoskeletal Diseases (2) · Nutrition Disorders (2) · Nutritional and Metabolic Diseases (2) · Vitamin D Deficiency (2) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Endocrine System Diseases (1)
asfotase alfa (1)
Alexion Pharmaceuticals, Inc. (1) · Bing Shu (1)
China (1)
Michael P. Whyte, MD (1) · Yongjun Wang, Doctor (1)